OVERLAP OF THE P53-RESPONSIVE ELEMENT AND CAMP-RESPONSIVE ELEMENT IN THE ENHANCER OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I

被引:44
作者
AOYAMA, N
NAGASE, T
SAWAZAKI, T
MIZUGUCHI, G
NAKAGOSHI, H
FUJISAWA, JI
YOSHIDA, M
ISHII, S
机构
[1] INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOLEC GENET LAB,TSUKUBA,IBARAKI 305,JAPAN
[2] UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN
[3] OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN
[4] SCI UNIV TOKYO,FAC PHARMACEUT SCI,SHINJUKU KU,TOKYO 162,JAPAN
关键词
TUMOR-SUPPRESSOR GENE; TRANSCRIPTIONAL ACTIVATION; DNA BINDING; FUNCTIONAL DOMAINS; POINT MUTANTS;
D O I
10.1073/pnas.89.12.5403
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The wild-type p53 protein suppresses transformation, but certain missense mutants of p53 can transform cells. Although the wild-type p53 protein contains a transcriptional activation domain, no p53-responsive element has been identified. Here, we identified the p53-responsive element within the Tax-responsive element [21-base-pair (bp) enhancer] of human T-cell leukemia virus type I. Mutation analysis of the 21-bp enhancer indicated that the 16-bp sequence containing the cAMP-responsive element and its surrounding sequence was responsible for p53-induced transactivation. This 16-bp sequence was demonstrated to bind specifically to wild-type human p53 protein in vitro. Using a series of deletion mutants of p53, we showed that almost the entire region of p53 is needed for the transactivating capacity. Furthermore, the transforming mutants of p53 were unable to act as transcriptional activators. The p53-responsive element identified here should be useful to analyze the mechanism by which p53 regulates expression of a set of genes with a negative effect on cellular growth.
引用
收藏
页码:5403 / 5407
页数:5
相关论文
共 46 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [3] WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION
    BARGONETTI, J
    FRIEDMAN, PN
    KERN, SE
    VOGELSTEIN, B
    PRIVES, C
    [J]. CELL, 1991, 65 (06) : 1083 - 1091
  • [4] MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC
    BLACKWOOD, EM
    EISENMAN, RN
    [J]. SCIENCE, 1991, 251 (4998) : 1211 - 1217
  • [5] MOUSE P53 INHIBITS SV40 ORIGIN-DEPENDENT DNA-REPLICATION
    BRAITHWAITE, AW
    STURZBECHER, HW
    ADDISON, C
    PALMER, C
    RUDGE, K
    JENKINS, JR
    [J]. NATURE, 1987, 329 (6138) : 458 - 460
  • [6] MYOD INDUCES GROWTH ARREST INDEPENDENT OF DIFFERENTIATION IN NORMAL AND TRANSFORMED-CELLS
    CRESCENZI, M
    FLEMING, TP
    LASSAR, AB
    WEINTRAUB, H
    AARONSON, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) : 8442 - 8446
  • [7] IDENTIFICATION OF A TRANSCRIPTIONAL ENHANCER ELEMENT UPSTREAM FROM THE PROTO-ONCOGENE FOS
    DESCHAMPS, J
    MEIJLINK, F
    VERMA, IM
    [J]. SCIENCE, 1985, 230 (4730) : 1174 - 1177
  • [8] DILLER L, 1990, MOL CELL BIOL, V10, P5775
  • [9] PARTICIPATION OF P53 CELLULAR TUMOR-ANTIGEN IN TRANSFORMATION OF NORMAL EMBRYONIC-CELLS
    ELIYAHU, D
    RAZ, A
    GRUSS, P
    GIVOL, D
    OREN, M
    [J]. NATURE, 1984, 312 (5995) : 646 - 649
  • [10] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767